Advancements in CAR T-Cell Therapy: A Promising Clinical Outlook
A recent phase 1 dose escalation trial has unveiled compelling data on a new wave of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy, marking a significant leap in the evolution…
StefanDecember 27, 2023






